SEC Form 4 · accession 0001225208-16-028092
WEST PHARMACEUTICAL SERVICES INC · WST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Warwick Bedwell
Officer — President, Pharma Pkgs Systems
Period of report
Feb 23, 2016
Accepted (ET)
Feb 25, 2016 · 10:58 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 23, 2016 | A | 4,613 | $59.64 | A | 38,778 | D | |
| Common Stock | Feb 23, 2016 | M | 3,680 | $54.14 | A | 42,458 | D | |
| Common StockF2 | Feb 23, 2016 | S | 3,680 | $58.8405 | D | 38,778 | D | |
| Common Stock | Feb 24, 2016 | M | 3,616 | $47.34 | A | 42,394 | D | |
| Common StockF3,F4 | Feb 24, 2016 | S | 3,616 | $59.2347 | D | 38,778 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $54.14 | Feb 23, 2016 | M | 3,680 | D | Feb 23, 2016 | Feb 23, 2025 | Common Stock | 3,680 | 11,040 | D |
| Stock Option (Right to Buy) | $59.64 | Feb 23, 2016 | A | 13,012 | A | Feb 23, 2017 | Feb 23, 2026 | Common Stock | 13,012 | 13,012 | D |
| Stock Option (Right to Buy) | $47.34 | Feb 24, 2016 | M | 3,616 | D | Feb 24, 2015 | Feb 24, 2024 | Common Stock | 3,616 | 7,232 | D |
Explanation of responses
- F1Shares represent the portion of the Performance Share Unit Award granted in 2013 that have vested for period 12.
- F2This was multiple transactions on the same date with prices in the range of $58.69 to $58.98. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.
- F3This was multiple transactions on the same date with prices in the range of $59.01 to $59.40. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.
- F4Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.